Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/10/16  and contains information from public web pages.

Dr. Herbert T. Nagasawa

Wrong Dr. Herbert T. Nagasawa?

Assistant Professor of Medicinal ...

Phone: (612) ***-****  HQ Phone
University of Minnesota
MMC 807 420 Delaware Street S.E.
Minneapolis , Minnesota 55455
United States

Company Description: Established in 1985, the University of Minnesota's Center for Bioethics is a nationally prominent, yet locally focused, resource that conducts important research...   more
Background

Education

  • National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium
  • B.S. degree , chemistry
    Western Reserve University
  • Ph.D.
  • Ph.D. degree , organic chemistry
    University of Minnesota
  • Ph.D.'s RiboCeine invention
200 Total References
Web References
Glutathione | Boston Hormone Replacement Therapy
www.bostontestosterone.com [cached]
Read also the following excerpt from Dr. Herbert Nagasawa, one of the worlds leading research scientists on cellular function.
...
Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and a Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973.
Dr. Nagasawa has held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health.
Dr. Nagasawa has published over 165 papers in peer-reviewed journals. In June of 2010, Dr. Nagasawa and his team attended the National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium to present their work on the cyanide antidote.
Dr. Nagasawa ha long been regarded as one of the worlds leading research scientists on cellular function, Glutathione and the chemistry and delivery of Glutathione. He and his laboratory have be awarded an extraordinary 9 patents.
Max International
maxgxl.com [cached]
RiboCeine was developed by the world-renowned research scientist and medicinal chemist, Herbert T. Nagasawa, Ph.D. Dr. Nagasawa was a Professor of Medicinal Chemistry and Toxicology at the University of Minnesota for forty years and at the same time he was named Senior Career Research Scientist for the Veterans Administration in Minneapolis. For thirty-two of those years he was Senior Editor of the Journal of Medicinal Chemistry. Dr. Nagasawa now serves as the Executive Scientist for Max International.
Max International
maxgxl.com [cached]
The creator of RiboCeine™ - Herbert T. Nagasawa, Ph.D., Executive Research Scientist
Chief Scientist and co-founder of CellGevity, Inc., Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and the Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals, and is the inventor named on ten U.S. and PCT patent applications.
Max International
maxgxl.com [cached]
RiboCeine was developed by the world-renowned research scientist and medicinal chemist, Herbert T. Nagasawa, Ph.D. Dr. Nagasawa was a Professor of Medicinal Chemistry and Toxicology at the University of Minnesota for forty years and at the same time he was named Senior Career Research Scientist for the Veterans Administration in Minneapolis. For thirty-two of those years he was Senior Editor of the Journal of Medicinal Chemistry. Dr. Nagasawa now serves as the Executive Scientist for Max International.
Max International
maxgxl.com [cached]
The creator of RiboCeine™ - Herbert T. Nagasawa, Ph.D., Executive Research Scientist
Chief Scientist and co-founder of CellGevity, Inc., Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and the Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals, and is the inventor named on ten U.S. and PCT patent applications.
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304